pubmed.ncbi.nlm.nih.gov

Immunological and inflammatory functions of the interleukin-1 family - PubMed

Review

Immunological and inflammatory functions of the interleukin-1 family

Charles A Dinarello. Annu Rev Immunol. 2009.

Abstract

More than any other cytokine family, the interleukin (IL)-1 family is closely linked to the innate immune response. This linkage became evident upon the discovery that the cytoplasmic domain of the IL-1 receptor type I is highly homologous to the cytoplasmic domains of all Toll-like receptors (TLRs). Thus, fundamental inflammatory responses such as the induction of cyclooxygenase type 2, increased expression of adhesion molecules, or synthesis of nitric oxide are indistinguishable responses of both IL-1 and TLR ligands. Both families nonspecifically affect antigen recognition and lymphocyte function. IL-1beta is the most studied member of the IL-1 family because of its role in mediating autoinflammatory diseases. Although the TLR and IL-1 families evolved to assist in host defense against infection, unlike the TLR family, the IL-1 family also includes members that suppress inflammation, both specifically within the IL-1 family but also nonspecifically for TLR ligands and the innate immune response.

PubMed Disclaimer

Cited by

The pathogenic responses elicited during exposure of human intestinal cell line with Giardia duodenalis excretory-secretory products and the potential attributed endocytosis mechanism.
Yu X, Yang Y, Zhu W, Liu M, Wu J, Singer SM, Li W. Yu X, et al. Med Microbiol Immunol. 2024 Oct 23;213(1):23. doi: 10.1007/s00430-024-00806-y. Med Microbiol Immunol. 2024. PMID: 39441372
EDNRA affects susceptibility to large artery atherosclerosis stroke through potential inflammatory pathway.
Xu Z, Zhou Q, Liu C, Zhang H, Bai N, Xiang T, Luo D, Liu H. Xu Z, et al. Sci Rep. 2024 Oct 24;14(1):25173. doi: 10.1038/s41598-024-76190-7. Sci Rep. 2024. PMID: 39448657 Free PMC article.
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials.
Scisciola L, Cataldo V, Taktaz F, Fontanella RA, Pesapane A, Ghosh P, Franzese M, Puocci A, De Angelis A, Sportiello L, Marfella R, Barbieri M. Scisciola L, et al. Front Cardiovasc Med. 2022 Sep 6;9:1008922. doi: 10.3389/fcvm.2022.1008922. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36148061 Free PMC article. Review.
Exploring the role of IL-1β in inflammatory bowel disease pathogenesis.
Aggeletopoulou I, Kalafateli M, Tsounis EP, Triantos C. Aggeletopoulou I, et al. Front Med (Lausanne). 2024 Jan 22;11:1307394. doi: 10.3389/fmed.2024.1307394. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38323035 Free PMC article. Review.
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives.
Ozaki E, Campbell M, Doyle SL. Ozaki E, et al. J Inflamm Res. 2015 Jan 16;8:15-27. doi: 10.2147/JIR.S51250. eCollection 2015. J Inflamm Res. 2015. PMID: 25653548 Free PMC article. Review.

Immunological and inflammatory functions of the interleukin-1 family - PubMed